These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2169547)

  • 1. [Changes in ketone body ratio and levels of pyruvate and lactate in arterial blood of patients with hepatocellular carcinoma after transcatheter arterial embolization].
    Mizobuchi N; Kuwao F; Takeda I; Takemura T; Morita S; Horimi T; Takahashi I
    Rinsho Byori; 1990 Jul; 38(7):825-9. PubMed ID: 2169547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc metabolism after transcatheter arterial embolization for hepatocellular carcinoma.
    Ohmoto K; Yamamoto S
    Hepatogastroenterology; 1998; 45(22):1082-4. PubMed ID: 9756010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic arteriovenous shunting due to hepatocellular carcinoma and cirrhosis, and its change by transcatheter arterial embolization.
    Sugano S; Miyoshi K; Suzuki T; Kawafune T; Kubota M
    Am J Gastroenterol; 1994 Feb; 89(2):184-8. PubMed ID: 8304300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
    Hasegawa I; Hirashima N
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of spontaneous bleeding due to hepatocellular carcinoma.
    Recordare A; Bonariol L; Caratozzolo E; Callegari F; Bruno G; Di Paola F; Bassi N
    Minerva Chir; 2002 Jun; 57(3):347-56. PubMed ID: 12029230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rupture of hepatocellular carcinoma after transcatheter arterial embolization: an unusual case.
    Sakamoto Y; Kita Y; Takayama T; Kawauchi N; Minagawa M; Makuuchi M
    Hepatogastroenterology; 1999; 46(25):453-6. PubMed ID: 10228840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of partial splenic embolization (PSE) in hepatocellular carcinomas showing a risk of gastrointestinal bleeding after transcatheter arterial embolization (TAE)].
    Ohmoto K; Yamamoto R; Yamamoto S; Ideguchi S; Saito I; Wada A; Takatori K; Ohumi T; Hino K; Hirano Y
    Gan No Rinsho; 1989 May; 35(6):690-5. PubMed ID: 2542638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in serum human hepatocyte growth factor levels after transcatheter arterial embolization and partial hepatectomy.
    Kaneko A; Hayashi N; Tanaka Y; Ito T; Kasahara A; Kubo M; Mukuda T; Fusamoto H; Kamada T
    Am J Gastroenterol; 1992 Aug; 87(8):1014-7. PubMed ID: 1322635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transcatheter arterial embolization with hepatic arterial induction of endogenous TNF in hepatocellular carcinoma].
    Takekoshi H; Oyama R
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2845-8. PubMed ID: 2476966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter partial splenic arterial embolization in patients with hypersplenism: a clinical evaluation as supporting therapy for hepatocellular carcinoma and liver cirrhosis.
    Hirai K; Kawazoe Y; Yamashita K; Kumagai M; Tanaka M; Sakai T; Inoue R; Eguchi S; Majima Y; Abe M
    Hepatogastroenterology; 1986 Jun; 33(3):105-8. PubMed ID: 3017829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
    Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
    Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum interleukin 6 as a predicator of the therapeutic effect and adverse reactions after transcatheter arterial embolization.
    Yamazaki H; Nishimoto N; Oi H; Matsushita M; Ogata A; Shima Y; Inoue T; Tang JT; Yoshizaki K; Kishimoto T
    Cytokine; 1995 Feb; 7(2):191-5. PubMed ID: 7780039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of transcatheter arterial embolization of primary hepatocellular carcinoma: discrepancy in different histopathologic subtypes.
    Wang Y; Zhang J; Gao Y; Yu M; Gong Y; Yu G
    Chin Med J (Engl); 1999 Mar; 112(3):264-8. PubMed ID: 11593564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transcatheter arterial embolization for advanced hepatocellular carcinoma--indications and limitations].
    Nakamura H; Kawata S; Takamura M; Osuga K; Murakami T
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1509-15. PubMed ID: 11015994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic perfusion index in evaluating treatment effect of transcatheter hepatic artery embolization in patients with hepatocellular carcinoma.
    Lin WY; Wang SJ; Yeh SH
    Neoplasma; 1995; 42(2):89-92. PubMed ID: 7617083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
    Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of transcatheter hepatic arterial embolization on coagulation and fibrinolysis in patients with hepatocellular carcinoma.
    Sakon M; Kambayashi J; Taniguchi K; Yoshida T; Shiba E; Kawasaki T; Tsuji Y; Yukawa M; Murata K; Gotoh M
    Am J Gastroenterol; 1991 Dec; 86(12):1800-3. PubMed ID: 1660219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant increase in the antibody to Gal alpha 1-3Gal structure in sera of patients with hepatocellular carcinoma after transcatheter arterial embolization.
    Kashiwagi M; Ikeda Y; Iwamori M; Toda G; Nagai Y
    Cancer Res; 1989 Aug; 49(16):4396-401. PubMed ID: 2545342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
    Jin-no K
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.